Delivery Order SPE2DB20D2014-SPE2DB25FC23Y
Award Date
6/17/25
Potential Completion Date
6/18/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,355.00 fixed-price delivery order is for the supply of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,252.28, is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 24, 2025. The contract was not set aside for any specific...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,354.77, is for the delivery of 4 mg Naloxone HCl Nasal Spray, a critical medication used to treat opioid overdoses. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 2, 2025. The contract has no set-aside designation, indicating open competition....
This federal contract award, valued at $2,667.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566961838 - NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of January 17, 2025. Amerisourcebergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,957.10 firm fixed-price contract is for the supply of Naloxone HCL 4 mg nasal spray, a medication used to treat opioid overdose. The contract has a performance period ending on June 17, 2025. AmerisourceBergen Drug Corp is the prime contractor, with no subcontractors mentioned. This contract is not designated as a set-aside....
This federal contract award, with a ceiling value of $1,379.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4564881464 - NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and it has an ultimate completion date of June 13, 2024. The contract is not associated with a set-aside...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a ceiling value of $1,315.16 and a completion date of November 13, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $1,838.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,999,320 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. This delivery order contract has a firm fixed-price pricing type and an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp also...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naloxone HCl 4 mg nasal spray, a drug used to treat opioid overdoses. The contract has a ceiling value of $13,223.11 and is a firm fixed-price delivery order, with a completion date of June 4, 2025. The contract is not set aside and is open to full and open competition....
This federal contract award is for the delivery of 4565179191 - NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2024 with a completion date of July 18, 2024. The contract has a ceiling value of $1,605.50 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this contract....